Cargando…

Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease

BACKGROUND: Subjects at risk for major mood disorders have a higher risk to develop autoimmune thyroid disease (AITD) and vice-versa, implying a shared pathogenesis. In mood disorder patients, an abnormal profile of hematopoietic/neuronal growth factors is observed, suggesting that growth/differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Massolt, Elske T., Effraimidis, Grigoris, Korevaar, Tim I. M., Wiersinga, Wilmar M., Visser, W. Edward, Peeters, Robin P., Drexhage, Hemmo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836766/
https://www.ncbi.nlm.nih.gov/pubmed/27092550
http://dx.doi.org/10.1371/journal.pone.0153892
_version_ 1782427780748673024
author Massolt, Elske T.
Effraimidis, Grigoris
Korevaar, Tim I. M.
Wiersinga, Wilmar M.
Visser, W. Edward
Peeters, Robin P.
Drexhage, Hemmo A.
author_facet Massolt, Elske T.
Effraimidis, Grigoris
Korevaar, Tim I. M.
Wiersinga, Wilmar M.
Visser, W. Edward
Peeters, Robin P.
Drexhage, Hemmo A.
author_sort Massolt, Elske T.
collection PubMed
description BACKGROUND: Subjects at risk for major mood disorders have a higher risk to develop autoimmune thyroid disease (AITD) and vice-versa, implying a shared pathogenesis. In mood disorder patients, an abnormal profile of hematopoietic/neuronal growth factors is observed, suggesting that growth/differentiation abnormalities of these cell lineages may predispose to mood disorders. The first objective of our study was to investigate whether an aberrant profile of these hematopoietic/neuronal growth factors is also detectable in subjects at risk for AITD. A second objective was to study the inter relationship of these factors with previously determined and published growth factors/cytokines in the same subjects. METHODS: We studied 64 TPO-Ab-negative females with at least 1 first- or second-degree relative with AITD, 32 of whom did and 32 who did not seroconvert to TPO-Ab positivity in 5-year follow-up. Subjects were compared with 32 healthy controls (HCs). We measured serum levels of brain-derived neurotrophic factor (BDNF), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF) and IL-7 at baseline. RESULTS: BDNF was significantly lower (8.2 vs 18.9 ng/ml, P<0.001), while EGF (506.9 vs 307.6 pg/ml, P = 0.003) and IGFBP-2 (388.3 vs 188.5 ng/ml, P = 0.028) were significantly higher in relatives than in HCs. Relatives who seroconverted in the next 5 years had significantly higher levels of SCF than non-seroconverters (26.5 vs 16.7 pg/ml, P = 0.017). In a cluster analysis with the previously published growth factors/cytokines SCF clustered together with IL-1β, IL-6 and CCL-3, of which high levels also preceded seroconversion. CONCLUSION: Relatives of AITD patients show aberrant serum levels of 4 hematopoietic/neuronal growth factors similar to the aberrancies found in mood disorder patients, suggesting that shared growth and differentiation defects in both the hematopoietic and neuronal system may underlie thyroid autoimmunity and mood disorders. A distinct pattern of four inter correlating immune factors in the relatives preceded TPO-Ab seroconversion in the next 5 years.
format Online
Article
Text
id pubmed-4836766
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48367662016-04-29 Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease Massolt, Elske T. Effraimidis, Grigoris Korevaar, Tim I. M. Wiersinga, Wilmar M. Visser, W. Edward Peeters, Robin P. Drexhage, Hemmo A. PLoS One Research Article BACKGROUND: Subjects at risk for major mood disorders have a higher risk to develop autoimmune thyroid disease (AITD) and vice-versa, implying a shared pathogenesis. In mood disorder patients, an abnormal profile of hematopoietic/neuronal growth factors is observed, suggesting that growth/differentiation abnormalities of these cell lineages may predispose to mood disorders. The first objective of our study was to investigate whether an aberrant profile of these hematopoietic/neuronal growth factors is also detectable in subjects at risk for AITD. A second objective was to study the inter relationship of these factors with previously determined and published growth factors/cytokines in the same subjects. METHODS: We studied 64 TPO-Ab-negative females with at least 1 first- or second-degree relative with AITD, 32 of whom did and 32 who did not seroconvert to TPO-Ab positivity in 5-year follow-up. Subjects were compared with 32 healthy controls (HCs). We measured serum levels of brain-derived neurotrophic factor (BDNF), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF) and IL-7 at baseline. RESULTS: BDNF was significantly lower (8.2 vs 18.9 ng/ml, P<0.001), while EGF (506.9 vs 307.6 pg/ml, P = 0.003) and IGFBP-2 (388.3 vs 188.5 ng/ml, P = 0.028) were significantly higher in relatives than in HCs. Relatives who seroconverted in the next 5 years had significantly higher levels of SCF than non-seroconverters (26.5 vs 16.7 pg/ml, P = 0.017). In a cluster analysis with the previously published growth factors/cytokines SCF clustered together with IL-1β, IL-6 and CCL-3, of which high levels also preceded seroconversion. CONCLUSION: Relatives of AITD patients show aberrant serum levels of 4 hematopoietic/neuronal growth factors similar to the aberrancies found in mood disorder patients, suggesting that shared growth and differentiation defects in both the hematopoietic and neuronal system may underlie thyroid autoimmunity and mood disorders. A distinct pattern of four inter correlating immune factors in the relatives preceded TPO-Ab seroconversion in the next 5 years. Public Library of Science 2016-04-19 /pmc/articles/PMC4836766/ /pubmed/27092550 http://dx.doi.org/10.1371/journal.pone.0153892 Text en © 2016 Massolt et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Massolt, Elske T.
Effraimidis, Grigoris
Korevaar, Tim I. M.
Wiersinga, Wilmar M.
Visser, W. Edward
Peeters, Robin P.
Drexhage, Hemmo A.
Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title_full Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title_fullStr Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title_full_unstemmed Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title_short Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease
title_sort aberrant levels of hematopoietic/neuronal growth and differentiation factors in euthyroid women at risk for autoimmune thyroid disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836766/
https://www.ncbi.nlm.nih.gov/pubmed/27092550
http://dx.doi.org/10.1371/journal.pone.0153892
work_keys_str_mv AT massoltelsket aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT effraimidisgrigoris aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT korevaartimim aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT wiersingawilmarm aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT visserwedward aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT peetersrobinp aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease
AT drexhagehemmoa aberrantlevelsofhematopoieticneuronalgrowthanddifferentiationfactorsineuthyroidwomenatriskforautoimmunethyroiddisease